These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. High-performance liquid chromatographic method for the determination of the three main oxidative and 3-carboxylic antipyrine metabolites in human urine. Palette C, Cordonnier P, Naline E, Advenier C, Pays M. J Chromatogr; 1991 Jan 18; 563(1):103-13. PubMed ID: 2061375 [Abstract] [Full Text] [Related]
30. Relationship between the metabolism of antipyrine, hexobarbital and theophylline in patients with liver disease as assessed by a 'cocktail' approach. Schellens JH, Janssens AR, van der Wart JH, van der Velde EA, Breimer DD. Eur J Clin Invest; 1989 Oct 18; 19(5):472-9. PubMed ID: 2511024 [Abstract] [Full Text] [Related]
31. Correlation between antipyrine metabolite formation and theophylline metabolism in humans after simultaneous single-dose administration and at steady state. Teunissen MW, De Leede LG, Boeijinga JK, Breimer DD. J Pharmacol Exp Ther; 1985 Jun 18; 233(3):770-5. PubMed ID: 4009489 [Abstract] [Full Text] [Related]
32. Assay of antipyrine and its main metabolites 3-hydroxymethylantipyrine, norantipyrine and 4-hydroxyantipyrine in urine. Brendel E, Meineke I, de Mey C. J Pharm Biomed Anal; 1989 Jun 18; 7(12):1783-90. PubMed ID: 2490567 [Abstract] [Full Text] [Related]
33. Changes in metabolism and urinary excretion of antipyrine induced by aerobic conditioning. Villa JG, Bayon JE, González-Gallego J. J Sports Med Phys Fitness; 1999 Sep 18; 39(3):197-201. PubMed ID: 10573660 [Abstract] [Full Text] [Related]
34. Physical exercise and improvement of liver oxidative metabolism in the elderly. Mauriz JL, Tabernero B, García-López J, Jorquera F, Villa JG, González-Gallego J. Eur J Appl Physiol; 2000 Jan 18; 81(1-2):62-6. PubMed ID: 10552268 [Abstract] [Full Text] [Related]
36. Influence of liver damage on antipyrine metabolite formation in rats. Tanaka E, Etoh H, Ishikawa A, Nakano M, Misawa S. Xenobiotica; 1991 May 18; 21(5):663-7. PubMed ID: 1949899 [Abstract] [Full Text] [Related]
37. Diltiazem treatment impairs hepatic drug oxidation: studies of antipyrine. Carrum G, Egan JM, Abernethy DR. Clin Pharmacol Ther; 1986 Aug 18; 40(2):140-3. PubMed ID: 3731677 [Abstract] [Full Text] [Related]
38. Differential effects of enzyme induction on antipyrine metabolite formation. Danhof M, Verbeek RM, van Boxtel CJ, Boeijinga JK, Breimer DD. Br J Clin Pharmacol; 1982 Mar 18; 13(3):379-86. PubMed ID: 7059438 [Abstract] [Full Text] [Related]
39. The influence of aging on the metabolism of simultaneously administered hexobarbital enantiomers and antipyrine before and after phenobarbital induction in male rats: a longitudinal study. Groen K, Breimer DD, Jansen EJ, van Bezooijen CF. J Pharmacol Exp Ther; 1994 Feb 18; 268(2):531-6. PubMed ID: 8113964 [Abstract] [Full Text] [Related]
40. The effect of sex on antipyrine metabolism in cattle at different ages. Janus K, Antoszek J. J Vet Pharmacol Ther; 1999 Jun 18; 22(3):163-9. PubMed ID: 10447826 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]